Colorectal cancer is the second leading cause of cancer deaths, but despite its rising rates, particularly in younger individuals, it remains underfunded and less known compared to other cancers. The Colorectal Cancer Alliance’s “Project Cure CRC” aims to invest $100 million in innovative research to tackle this issue. Recent grants fund groundbreaking studies targeting advanced CRC therapies, early detection, and treatment options for BRAF-mutated colorectal cancer. The project emphasizes urgency in research, seeking novel, effective treatments and partnerships to combat CRC.
Keep Reading
Add A Comment